{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:41:04Z","timestamp":1784943664664,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011093","name":"University of Phayao","doi-asserted-by":"publisher","award":["FF64-UoE003"],"award-info":[{"award-number":["FF64-UoE003"]}],"id":[{"id":"10.13039\/501100011093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011093","name":"University of Phayao","doi-asserted-by":"publisher","award":["PHAR63001"],"award-info":[{"award-number":["PHAR63001"]}],"id":[{"id":"10.13039\/501100011093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jjcc.2020.12.015","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:01:21Z","timestamp":1610661681000},"page":"669-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand"],"prefix":"10.1016","volume":"77","author":[{"given":"Yuttana","family":"Wongsalap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirati","family":"Kengkla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangkamon","family":"Poolpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Saokaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2020.12.015_bib0001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3111\/13696998.2014.885907","article-title":"The economic impact of acute coronary syndrome on length of stay: an analysis using the Healthcare Cost and Utilization Project (HCUP) databases","volume":"17","author":"LaMori","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.hlc.2017.10.015","article-title":"All-cause mortality following an acute coronary syndrome: 12-year follow-up of the comprehensive 2002 New Zealand Acute Coronary Syndrome Audit","volume":"28","author":"Ellis","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0003","first-page":"508","article-title":"Thai Registry in Acute Coronary Syndrome (TRACS)\u2013an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year","volume":"95","author":"Srimahachota","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/clc.23238","article-title":"The prevalence of 30-day readmission after acute myocardial infarction: A systematic review and meta-analysis","volume":"42","author":"Wang","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0005","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0006","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0007","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0009","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0011","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0012","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0003319719895171","article-title":"Optimal medical therapy on top of dual-antiplatelet therapy: 1-year clinical outcome in patients with acute coronary syndrome: the START antiplatelet registry","volume":"71","author":"Cirillo","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0014","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ahj.2007.07.040","article-title":"Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome","volume":"154","author":"Yan","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amjcard.2017.11.002","article-title":"Effect of Optimal medical therapy at discharge in patients with reperfused ST-segment elevation myocardial infarction on 1-year mortality (from the Regional RESCUe Registry)","volume":"121","author":"Tomasevic","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0016","first-page":"167","article-title":"Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea","volume":"12","author":"Byeon","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0017","first-page":"100","article-title":"The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease","volume":"14","author":"Chen","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0018","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ehjcvp\/pvy005","article-title":"Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting","volume":"4","author":"Hoedemaker","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clinthera.2019.01.005","article-title":"Impact of optimal medical therapy at discharge on one-year direct medical costs in patients with acute coronary syndromes: a retrospective, observational database analysis in China","volume":"41","author":"He","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ahj.2008.09.026","article-title":"Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the clinical pathways for acute coronary syndromes in China (CPACS) study","volume":"157","author":"Bi","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0021","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ahj.2010.03.009","article-title":"Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value","volume":"159","author":"Lee","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0022","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American Heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A Wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0024","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/biostatistics\/kxs043","article-title":"Assessing the fit of parametric cure models","volume":"14","author":"Wileyto","year":"2013","journal-title":"Biostatistics (Oxford, England)"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0026","first-page":"124","article-title":"Inconsistency between univariate and multiple logistic regressions","volume":"29","author":"Wang","year":"2017","journal-title":"Shanghai Arch Psychiatry"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113677","article-title":"Augmented backward elimination: a pragmatic and purposeful way to develop statistical models","volume":"9","author":"Dunkler","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40256-018-0308-x","article-title":"Optimal medical therapy prescribing patterns and disparities identified in patients with acute coronary syndromes at an academic medical center in an area with high coronary heart disease-related mortality","volume":"19","author":"Fox","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0029","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0003319710394163","article-title":"Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events","volume":"62","author":"Al-Zakwani","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0030","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/heartjnl-2013-305296","article-title":"Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand","volume":"100","author":"Redfern","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0031","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.amjcard.2016.08.065","article-title":"Decade-long trends (2001 to 2011) in the use of evidence-based medical therapies at the time of hospital discharge for patients surviving acute myocardial infarction","volume":"118","author":"Makam","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0032","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2014.02.034","article-title":"Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"113","author":"Navarese","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0033","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0034","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0035","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.jacc.2017.03.585","article-title":"Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014","volume":"69","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0036","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jjcc.2019.08.012","article-title":"Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome","volume":"75","author":"Wongsalap","year":"2020","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0037","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10557-018-6810-1","article-title":"Trends in statin use 2009-2015 in a large integrated health system: pre- and post-2013 ACC\/AHA Guideline on Treatment of Blood Cholesterol","volume":"32","author":"Harrison","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0038","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjcard.2006.09.111","article-title":"Effects of high-dose atorvastatin in patients >or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study)","volume":"99","author":"Olsson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0039","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0041","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0042","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.amjmed.2005.01.070","article-title":"Medication performance measures and mortality following acute coronary syndromes","volume":"118","author":"Granger","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006460","article-title":"Lipid testing and statin dosing after acute myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2020.12.015_bib0044","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamacardio.2016.0001","article-title":"Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction","volume":"1","author":"Faridi","year":"2016","journal-title":"JAMA Cardiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:24:32Z","timestamp":1778549072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508721000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0914508721000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.12.015","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}